New NIH study published in Blood: Intriguing new concept of #GVHD prevention.
Phase 1/2 trial of high-dose palifermin (720 μg/kg) before RIC in MUD #HCT showed 0/19 patients developed classic grade 2–4 acute GVHD.
Thanks to mentor Steven Pavletic and NCI team!
🔗 doi.org/10.1182/bloo...

Life’s good, but the air isn’t. #Graz

Full text access to our review about iron chelation therapy in #MDSsm and allogeneic #HCT in Blood Reviews.

authors.elsevier.com/c/1lLPl,67Ou...

Spent 3 years at #NIH. Brought the mug home as a souvenir. Used it maybe 3 times. Figures.

Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges

www.sciencedirect.com/science/arti...

Download the full article for free at authors.elsevier.com/a/1k48s8THnh....

Link should be good until the end of this year!